Tags

Type your tag names separated by a space and hit enter

Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Ann Rheum Dis. 2005 Sep; 64(9):1387.AR

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

16100356

Citation

Gore, J, and R Silver. "Oral Sildenafil for the Treatment of Raynaud's Phenomenon and Digital Ulcers Secondary to Systemic Sclerosis." Annals of the Rheumatic Diseases, vol. 64, no. 9, 2005, p. 1387.
Gore J, Silver R. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Ann Rheum Dis. 2005;64(9):1387.
Gore, J., & Silver, R. (2005). Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Annals of the Rheumatic Diseases, 64(9), 1387.
Gore J, Silver R. Oral Sildenafil for the Treatment of Raynaud's Phenomenon and Digital Ulcers Secondary to Systemic Sclerosis. Ann Rheum Dis. 2005;64(9):1387. PubMed PMID: 16100356.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. AU - Gore,J, AU - Silver,R, PY - 2005/8/16/pubmed PY - 2005/10/7/medline PY - 2005/8/16/entrez SP - 1387 EP - 1387 JF - Annals of the rheumatic diseases JO - Ann. Rheum. Dis. VL - 64 IS - 9 SN - 0003-4967 UR - https://www.unboundmedicine.com/medline/citation/16100356/Oral_sildenafil_for_the_treatment_of_Raynaud's_phenomenon_and_digital_ulcers_secondary_to_systemic_sclerosis_ L2 - https://ard.bmj.com/cgi/pmidlookup?view=long&pmid=16100356 DB - PRIME DP - Unbound Medicine ER -